American International Group, Inc. Cyclerion Therapeutics, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.18 - $4.29 $28,139 - $55,375	-12,908 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$2.69 - $5.12 $91 - $174	34 Added 0.26%	12,908 $36,000
Q4 2020 Feb 12, 2021	SELL	$2.25 - $7.12 $832 - $2,634	-370 Reduced 2.79%	12,874 $39,000
Q3 2020 Nov 04, 2020	SELL	$3.46 - $8.39 $1,041 - $2,525	-301 Reduced 2.22%	13,244 $81,000
Q2 2020 Aug 12, 2020	SELL	$2.37 - $7.14 $1,026 - $3,091	-433 Reduced 3.1%	13,545 $80,000
Q1 2020 May 04, 2020	SELL	$2.46 - $5.84 $1,987 - $4,718	-808 Reduced 5.46%	13,978 $37,000
Q4 2019 Feb 05, 2020	SELL	$1.8 - $13.43 $223 - $1,665	-124 Reduced 0.83%	14,786 $40,000
Q3 2019 Nov 08, 2019	SELL	$8.12 - $14.54 $852 - $1,526	-105 Reduced 0.7%	14,910 $181,000
Q2 2019 Aug 13, 2019	BUY	$9.6 - $22.85 $144,144 - $343,092	15,015 New	15,015 $172,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $112M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.